You say the Israel Lobby is too influential, albeit in a way analogous to other lobbies; and you say that criticism of same shouldn’t be censored, or self-censored. Beyond creating a space for dissent, what do you propose be done to lessen the Israel Lobby’s influence?
Create a counter-lobby. Sure there is J Street, but it is almost always on the defensive, responding to absurd exaggerations from the other side. And anyway, it has no money. The only way to proceed, it seems to me, is to build a counter-opinion, a counter-consensus that the Israel Lobby is bad for America. Actually, it is even worse for Israel, but no one here cares about that. So it is all about creating a public space in which to discuss these things. Hence my essays.
Try this. And let's see how many employees there are:
J Street’s staff
Jeremy Ben-Ami, President. Hadar Susskind, Vice President of Policy and Strategy. Daniel Kohl, Vice President of Political Affairs. Rachel A. Lerner, Vice President of J Street Education Fund. Isaac Luria, Vice President of Communications and New Media. Carinne Luck, Vice President of Grassroots and Field Programs. Nan MacNamara, Vice President of Finance and Administration.
Communications and New Media
Amy Spitalnick, Press and New Media Associate. Zachary Teicher, Communications and Web Associate. Jeff Kulp, Web Assistant.
Dylan J. Williams, Deputy Director of Government Affairs. Rebecca Wasserman, Assistant Director of Government Affairs.
Kevin Rachlin, Government Affairs Associate.
Rachel Streitfeld, Government Affairs Associate.
J Street Education Fund
Aliza Becker, Director of Special Projects.
Sarah Beller, Director of Education and Programs.
Andrew Meyerson, Development & Communications Associate.
Julia Terlinchamp, Programming Associate
Elizabet Wendt, West Coast Organizer, J Street U.
J Street Local
Gordon Gladstone, Northern California/Northwest Regional Director. Anne Gregory, South/Southeast Regional Director. Kate Press, New York City Regional Director. Gillian Rosenberg, Midwest Regional Director.
Shira Barchilon Frank, Deputy Director of Development and Leadership Outreach. Daniel Kalik, PAC Manager. Daniel Rosove, Research and Program Assistant. Jesse Greenberg, Midwest Regional Political Director. Janette Hillis-Jaffe, New England Regional Political Director. Barbara Lahav, Pacific Northwest Regional Political Director. Adee Telem, New York Regional Political Director.
A lot of salaries to pay. Add to that the other running expenses.
Judt is so smart. Not.
And no public space to discuss antizionism, perversion of history?
Ha, ha, ha. Look at all the space out there, especially The Nation, The New York Review of Books, etc., etc., etc.
Judt is sick and dying (*) but he still doesn't get my sympathy.
In 2008, Judt was diagnosed with amyotrophic lateral sclerosis or ALS, also known as Lou Gehrig's Disease. As of October 2009, he was paralyzed from the neck down.
And even Israel can't help him, at the moment:
Teva Pharmaceutical Industries Ltd. said Monday its potential Lou Gehrig's disease treatment failed to meet a key goal in a midstage study. The company said Talampanel failed to meet its key goal of effectiveness in the study, which included 559 patients. The drug candidate did meet safety goals.
Lou Gehrig's disease is a fatal neurological disorder that steals the body's ability to move, speak and ultimately to breathe. Also known as amyotrophic lateral sclerosis, or ALS, it currently has no cure or treatment that halts or reverses the condition.
- - -